> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cell Tissue Panel to Discuss Toxicity Risks
- URL: https://www.fdaweb.com/cell-tissue-panel-to-discuss-toxicity-risks/
- Published: 2021-07-26T12:00:00.000Z
- Updated: 2026-09-14T17:07:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149779

*Federal Register* notice: FDA has announced a 9/2-3 Cellular, Tissue and Gene Therapies Advisory Committee meeting. Panel members are scheduled to discuss toxicity risks of adeno-associated virus vector-based gene therapy products. Specifically, they will discuss oncogenicity risks due to vector genome integration and safety issues identified during preclinical and/or clinical evaluation. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-07-26/pdf/2021-15783.pdf?ref=fdaweb.com).